Trou­bled AB Sci­ence claims break­out Alzheimer's suc­cess while vTv flops — again

Two drugs aimed at treat­ing Alzheimer’s dis­ease by tamp­ing down in­flam­ma­tion have racked up com­plete­ly op­po­site re­sults in Phase II tri­als — shin­ing a light on …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER